Clinical Trial Update: Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema [Phase 3]

View source ↗

Summary

Phase 3 trial of the AeriSeal System for advanced non-upper lobe predominant heterogeneous emphysema has been withdrawn from further study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• AeriSeal System

Snippet

Sponsor: Aeris Therapeutics | Conditions: Emphysema, Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: WITHDRAWN